Heron Therapeutics (HRTX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.36, -5.00% vs the prior close of $0.38.
- Volume 1.73M shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HRTX slides 5.0% to $0.36. Closed at $0.36, -5.00% vs the prior close of $0.38. Day range $0.35–$0.38, opened at $0.38.
HRTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HRTX slides 5.0% to $0.36
- Closed at $0.36, -5.00% vs the prior close of $0.38. Day range $0.35–$0.38, opened at $0.38.
- Volume was 1.73M shares, 0.6x its 50-day average of 2.70M.
- Price is +8.3% vs its 50-day average ($0.33) and -52.0% vs its 200-day average ($0.75).
- 52-week range $0.26–$1.58; today's close sits at 8% of that range, 77.2% below the 52-week high.
Oct 15, 2026 — HRTX jumps 5.6% to $0.38
- Closed at $0.38, +5.56% vs the prior close of $0.36. Day range $0.36–$0.40, opened at $0.37.
- Volume was 1.28M shares, 0.5x its 50-day average of 2.70M — lighter than usual.
- Price is +13.0% vs its 50-day average ($0.34) and -49.8% vs its 200-day average ($0.76).
- 52-week range $0.26–$1.58; today's close sits at 9% of that range, 75.9% below the 52-week high.
Oct 14, 2026 — HRTX slides 7.7% to $0.36
- Closed at $0.36, -7.69% vs the prior close of $0.39. Day range $0.36–$0.40, opened at $0.38.
- Volume was 2.09M shares, 0.8x its 50-day average of 2.69M.
- Price is +6.3% vs its 50-day average ($0.34) and -52.7% vs its 200-day average ($0.76).
- 52-week range $0.26–$1.58; today's close sits at 8% of that range, 77.2% below the 52-week high.
Oct 13, 2026 — HRTX slides 7.1% to $0.39
- Closed at $0.39, -7.14% vs the prior close of $0.42. Day range $0.38–$0.43, opened at $0.42.
- Volume was 1.86M shares, 0.7x its 50-day average of 2.68M.
- Price is +14.2% vs its 50-day average ($0.34) and -49.1% vs its 200-day average ($0.77).
- 52-week range $0.26–$1.58; today's close sits at 10% of that range, 75.3% below the 52-week high.
Oct 12, 2026 — HRTX rises 2.4% to $0.42, a 1-month high
- Closed at $0.42, +2.44% vs the prior close of $0.41. Day range $0.38–$0.42, opened at $0.40.
- Volume was 1.96M shares, 0.7x its 50-day average of 2.67M.
- Price is +22.1% vs its 50-day average ($0.34) and -45.5% vs its 200-day average ($0.77).
- 52-week range $0.26–$1.58; today's close sits at 12% of that range, 73.4% below the 52-week high.
Oct 9, 2026 — HRTX jumps 13.9% to $0.41, a 1-month high
- Closed at $0.41, +13.89% vs the prior close of $0.36. Day range $0.35–$0.41, opened at $0.35.
- Volume was 3.50M shares, 1.3x its 50-day average of 2.62M.
- Price is +18.6% vs its 50-day average ($0.35) and -47.1% vs its 200-day average ($0.78).
- 52-week range $0.26–$1.58; today's close sits at 11% of that range, 74.1% below the 52-week high.
Oct 8, 2026 — HRTX slides 5.3% to $0.36
- Closed at $0.36, -5.26% vs the prior close of $0.38. Day range $0.35–$0.38, opened at $0.37.
- Volume was 1.89M shares, 0.7x its 50-day average of 2.61M.
- Price is +3.6% vs its 50-day average ($0.35) and -53.8% vs its 200-day average ($0.78).
- 52-week range $0.26–$1.58; today's close sits at 8% of that range, 77.2% below the 52-week high.
Oct 7, 2026 — HRTX jumps 15.2% to $0.38, a 1-month high
- Closed at $0.38, +15.15% vs the prior close of $0.33. Day range $0.33–$0.39, opened at $0.33.
- Volume was 3.67M shares, 1.4x its 50-day average of 2.57M.
- Price is +8.6% vs its 50-day average ($0.35) and -51.6% vs its 200-day average ($0.78).
- 52-week range $0.26–$1.58; today's close sits at 9% of that range, 75.9% below the 52-week high.
Oct 6, 2026 — HRTX slides 10.8% to $0.33
- Closed at $0.33, -10.81% vs the prior close of $0.37. Day range $0.32–$0.38, opened at $0.37.
- Volume was 2.32M shares, 0.9x its 50-day average of 2.57M.
- Price is -6.3% vs its 50-day average ($0.35) and -58.2% vs its 200-day average ($0.79).
- 52-week range $0.26–$1.58; today's close sits at 5% of that range, 79.1% below the 52-week high.
Oct 5, 2026 — HRTX jumps 5.7% to $0.37, a 1-month high
- Closed at $0.37, +5.71% vs the prior close of $0.35. Day range $0.35–$0.38, opened at $0.36.
- Volume was 2.93M shares, 1.2x its 50-day average of 2.53M.
- Price is +4.3% vs its 50-day average ($0.35) and -53.4% vs its 200-day average ($0.79).
- 52-week range $0.26–$1.58; today's close sits at 8% of that range, 76.6% below the 52-week high.
Oct 2, 2026 — HRTX dips 2.8% to $0.35
- Closed at $0.35, -2.78% vs the prior close of $0.36. Day range $0.34–$0.41, opened at $0.36.
- Volume was 4.07M shares, 1.6x its 50-day average of 2.48M.
- Price is -1.9% vs its 50-day average ($0.36) and -56.2% vs its 200-day average ($0.80).
- 52-week range $0.26–$1.58; today's close sits at 7% of that range, 77.8% below the 52-week high.
HRTX latest news & SEC filings
Every SEC filing by or about HRTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.03 — Change to shareholder rights.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.49M (prior year -$2.38M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.03 (prior year -$0.02) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Things to know before you trade HRTX
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 26, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.59% (largest 16.1%). That is a volatile stock.
- Liquidity: about 2.71M shares (≈$976.54K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.36 vs a range of $0.26–$1.58 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Aug 14, 2026; 10-Q Aug 10, 2026.
- Share count: 189.85M shares outstanding (Aug 5, 2026), +23.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HRTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.38 | 0.38 | 0.35 | 0.36 | 1.73M |
| Oct 15, 2026 | 0.37 | 0.40 | 0.36 | 0.38 | 1.28M |
| Oct 14, 2026 | 0.38 | 0.40 | 0.36 | 0.36 | 2.09M |
| Oct 13, 2026 | 0.42 | 0.43 | 0.38 | 0.39 | 1.86M |
| Oct 12, 2026 | 0.40 | 0.42 | 0.38 | 0.42 | 1.96M |
| Oct 9, 2026 | 0.35 | 0.41 | 0.35 | 0.41 | 3.50M |
| Oct 8, 2026 | 0.37 | 0.38 | 0.35 | 0.36 | 1.89M |
| Oct 7, 2026 | 0.33 | 0.39 | 0.33 | 0.38 | 3.67M |
| Oct 6, 2026 | 0.37 | 0.38 | 0.32 | 0.33 | 2.32M |
| Oct 5, 2026 | 0.36 | 0.38 | 0.35 | 0.37 | 2.93M |
| Oct 2, 2026 | 0.36 | 0.41 | 0.34 | 0.35 | 4.07M |
| Oct 1, 2026 | 0.32 | 0.36 | 0.31 | 0.36 | 3.18M |
| Sep 30, 2026 | 0.31 | 0.34 | 0.30 | 0.31 | 2.47M |
| Sep 29, 2026 | 0.29 | 0.32 | 0.29 | 0.31 | 3.36M |
| Sep 28, 2026 | 0.29 | 0.30 | 0.28 | 0.29 | 1.12M |
| Sep 25, 2026 | 0.29 | 0.30 | 0.28 | 0.29 | 1.57M |
| Sep 24, 2026 | 0.30 | 0.30 | 0.28 | 0.29 | 929.80K |
| Sep 23, 2026 | 0.30 | 0.30 | 0.28 | 0.29 | 1.72M |
| Sep 22, 2026 | 0.28 | 0.31 | 0.27 | 0.30 | 3.87M |
| Sep 21, 2026 | 0.31 | 0.31 | 0.26 | 0.27 | 8.59M |
About Heron Therapeutics
Heron Therapeutics (HRTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 818033.
HRTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Waage Christian | Director | Feb 3, 2026 |
| Craig A Collard | Chief Executive Officer | Aug 3, 2026 |
| Thomas Cusack | Director | Feb 3, 2026 |
| Sharmila Dissanaike | Director | Feb 3, 2026 |
| Craig A Johnson | Director | Feb 3, 2026 |
| Michael Kaseta | Director | Feb 3, 2026 |
| Adam Morgan | Director | Feb 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Craig A Collard | Chief Executive Officer | Aug 3, 2026 |
| Ira Duarte | EVP, Chief Financial Officer | Aug 3, 2026 |
| William P Forbes | EVP, Chief Development Officer | Aug 3, 2026 |
| Mark Earl Hensley | Chief Operating Officer | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
HRTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-20.20M | -0.12 | $-27.59M |
| Dec 31, 2024 | — | $-13.58M | -0.09 | $-22.53M |
| Dec 31, 2023 | — | $-110.56M | -0.80 | $-58.79M |
| Dec 31, 2022 | — | $-182.02M | -1.67 | $-146.91M |
| Dec 31, 2021 | — | $-220.68M | -2.24 | $-203.35M |
Latest balance sheet: total assets $252.26M, total liabilities $245.35M, cash $20.72M (as of Jun 30, 2026).
HRTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $0.34 |
| May 11, 2026 | 8-K Item 2.02 (results) | $0.96 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $1.20 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $1.14 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $1.32 |
| May 6, 2025 | 8-K Item 2.02 (results) | $2.42 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $2.05 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.28 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HRTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.